Work

Abstract 1282: Phase I evaluation of STA-1474, a pro-drug of the novel HSP90 inhibitor STA-9090, in dogs with spontaneous cancer

Year: 2011

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2011-1282

Authors: Cheryl A. London, Misty D. Bear, Jennifer McCleese, Kevin P. Foley, Reji Paalangara, Takayo Inoue, Weiwen Ying, James Barsoum

Institutions: The Ohio State University, Synta Pharmaceuticals (United States)

Language: English

Topic: Veterinary Oncology Research

Subfield: Small Animals

Field: Veterinary

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2091024375

Cites:

Cited by: 1

Related to: 10